[{"type": "title", "data": "ED Venous Thrombosis Treatment (DVT or PE) (Patient Being Discharged Home)"}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Patient Education", "value": ""}, {"type": "sentence", "data": "Provide patient with follow up instructions in relation to Thrombosis follow up"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Refer to evidence link for Special Authority Forms", "value": ""}, {"type": "note", "data": "For patients with a contraindication to direct oral anticoagulation (such as eGFR less than 30 mL/min, liver cirrhosis, pregnant or breast feeding, body weight greater than 120 kg or impaired GI absorption) use Low Molecular Weight Heparin or page Thrombosis physician to discuss anticoagulation management", "value": ""}, {"type": "note", "data": "enoxaparin for eGFR 30 mL/min or greater and weight 100 kg or less:  \n- enoxaparin is dosed at 1.5 mg/kg subcutaneous qdaily", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "60 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "80 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "100 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "120 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "150 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "note", "data": "enoxaparin for eGFR 30 mL/min or greater and weight greater than 100 kg:  \n- enoxaparin is dosed at 1 mg/kg subcutaneous BID and arrangements should be made for patients to receive BID dosing after discharge   \n- Where BID dosing is not feasible, may select dalteparin for once daily dosing", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "100 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "120 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "150 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "note", "data": "enoxaparin for eGFR 10 to 29 mL/min", "value": ""}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "40 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "60 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "80 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "100 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "120 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "150 mg, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "note", "data": "dalteparin for eGFR 30 mL/min or greater  \n- For patients with cancer, or for patients greater than 100 kg", "value": ""}, {"type": "order", "data": "dalteparin", "value": ""}, {"type": "sentence", "data": "10,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "12,500 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "15,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "16,500 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "18,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "20,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "22,500 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "25,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "26,500 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "sentence", "data": "28,000 unit, subcutaneous, once, drug form: syringe-inj, first dose: NOW"}, {"type": "order", "data": "apixaban", "value": ""}, {"type": "sentence", "data": "10 mg, PO, once, drug form: tab, first dose: NOW"}, {"type": "note", "data": "Avoid rivaroxaban for eGFR less than 30 mL/min", "value": ""}, {"type": "order", "data": "rivaroxaban", "value": ""}, {"type": "sentence", "data": "15 mg, PO, once, drug form: tab, first dose: NOW"}, {"type": "note", "data": "Discharge Prescriptions", "value": ""}, {"type": "prescription", "data": "apixaban", "value": ""}, {"type": "sentence", "data": "10 mg, PO, BID, drug form: tab, dispense qty: 7 day"}, {"type": "prescription", "data": "rivaroxaban", "value": ""}, {"type": "sentence", "data": "15 mg, PO, BID, drug form: tab, dispense qty: 7 day"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC and Differential", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC CBC", "value": ""}, {"type": "sentence", "data": "Whole Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC Hemoglobin", "value": ""}, {"type": "sentence", "data": "once, Urgent"}, {"type": "order", "data": "INR and PTT Panel", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC INR Level", "value": ""}, {"type": "sentence", "data": "once, Urgent"}, {"type": "order", "data": "Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "POC Basic Metabolic Panel (Lytes, Urea, Creat, Gluc)", "value": ""}, {"type": "sentence", "data": "Whole Blood, Urgent, Collection: T;N, once"}, {"type": "order", "data": "Liver Panel (Bilirubin, ALP, Alb, ALT, GGT)", "value": ""}, {"type": "sentence", "data": "Blood, Urgent, Collection: T;N, once"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "US Lower Extremity and Ven Doppler BILAT", "value": ""}, {"type": "sentence", "data": "Routine, Order for future visit"}, {"type": "order", "data": "US Lower Extremity and Ven Doppler Left", "value": ""}, {"type": "sentence", "data": "Routine, Order for future visit"}, {"type": "order", "data": "US Lower Extremity and Ven Doppler Right", "value": ""}, {"type": "sentence", "data": "Routine, Order for future visit"}, {"type": "category", "data": "Consults/Referrals"}, {"type": "note", "data": "Consider consultation with Thrombosis Clinic", "value": ""}, {"type": "note", "data": "Click On Reference Text for each of the following referral orders for Inclusion and Exclusion Criteria", "value": ""}, {"type": "order", "data": "Referral to Outpatient SPH Thrombosis Clinic (ED VTE Pathway)", "value": ""}, {"type": "sentence", "data": "Within 24 hours, SPH Thrombosis"}, {"type": "order", "data": "Referral to Outpatient VGH Thrombosis (Acute VTE Treatment)", "value": ""}, {"type": "sentence", "data": "Within 24 hours, Paper Referral (See Reference Text)"}, {"type": "order", "data": "Referral to Clinic Not Using CST Cerner", "value": ""}, {"type": "sentence", "data": "Paper Referral, For patients requiring referral to Thrombosis Clinic for Venous Thrombosis Treatment (DVT or PE)"}]
